신풍제약

019170KOSPI의약품 제조업

45.8 / 100

Reference Date: 2026-06-10

Financial Score15.0 / 40

News Sentiment18.8 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but PER raises overvaluation concerns. Plunged 20.9% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Shinpoong Pharmaceutical is enhancing its competitiveness in the highly competitive domestic pharmaceutical market through global new drug development, improved generics, and first-generic launches, while focusing investments on high-profit products to improve profitability. Although sales increased by approximately 10.42% compared to the previous period, the company still recorded an operating loss due to ongoing R&D expenses.

Number of Employees

792people

Average Salary

77.1M KRW

Score Calculation Basis

Detailed Financial Score

PER

54.55Industry Average 11.930.0Point

4.6x industry avg (risky)

PBR

1.69Industry Average 0.891.0Point

1.9x industry avg (risky)

ROE

3.17Industry Average 4.012.5Point

Below industry avg

Debt Ratio

5.48Industry Average 12.436.5Point

Half of industry avg (excellent)

Trend 2023~20255.0 / 10 points

Revenue Growth Rate

2.0 / 3

Avg ▲8.3% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲113.3% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -7.2% (improving, 3yr)

Detailed News Sentiment

3 totalPositive 2Neutral 0Negative 1Average Sentiment Score 75

Positive
식약처, 아세안 GMP 협력 강화…국내 제약사 동남아 진출 지원
신풍제약의 동남아시아 시장 진출 지원이 강화되어 긍정적인 영향 기대.
Negative
[축제의 그늘]④ 자본시장의 역사가 보내는 경고… 잔치는 가장 화려.....
최근 시장 과열과 함께 신풍제약을 포함한 여러 기업들이 고점 대비 큰 하락을 겪고 있어 부정적인 영향이 예상됩니다.
Positive
[특징주] 한타바이러스 글로벌 확산 우려에 관련株 급등
신풍제약 주가 급등: 한타바이러스 글로벌 확산 우려로 제약 및 진단키트 관련주가 상승.

Detailed Momentum

52-week position1.0Point

Near 52w low (0%, downtrend)

Current 8,730Won52-week high 17,83052-week low 8,730

1-month return0.0Point

1m -20.85% (strong drop)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

2 totalPositive 0Neutral 2Negative 0

Neutral기업지배구조보고서공시2026-05-29
Neutral분기보고서 (2026.03)2026-05-15